• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 170
  • 77
  • 71
  • 30
  • 19
  • 16
  • 10
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • Tagged with
  • 527
  • 128
  • 93
  • 75
  • 64
  • 62
  • 59
  • 55
  • 52
  • 50
  • 47
  • 43
  • 42
  • 41
  • 41
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
321

Bone Morphogenetic Protein-7 (bmp-7) Polarizes Monocytes Into M2 Macrophages

Rocher, Crystal 01 January 2013 (has links)
Atherosclerosis is an inflammatory disease in which an accumulation of fatty acids and cholesterol occurs to form a plaque in small and large arteries. Monocyte polarization to classic M1 macrophages or alternative M2 macrophages is an important area of research that can determine the severity of disease progression. BMP-7 is a key growth factor responsible for directing differentiation of mesenchymal stem cells into brown fat cells, suggesting a role of BMP-7 in cellular plasticity; however, its role in monocyte polarization is yet to be revealed. In the current study, we hypothesize that monocyte treatment with BMP-7 will significantly result in increased polarization of monocytes into M2 macrophages and increased expression of anti-inflammatory cytokines. To that effect, we have established a stress induced cell culture system with monocytes (THP-1 cells) and apoptotic conditioned medium (ACM), simulating injury, to understand the effects of BMP-7 on M2 macrophage polarization from monocytes. Our data demonstrates that the BMP type 2 receptor (BMPR2) is found on monocytes and its activation is significantly (p
322

Testing Mice at Risk of Pancreatic Cancer for Altered Protein Pathways Found in Diabetes

Cheung, Henley 01 January 2017 (has links)
Pancreatic cancer is nearly asymptomatic, which can result in extensive grow and even metastasis to other organs before detection. When diagnosed at a late stage, the survival rate is 3%. Early detection is therefore the key to treating pancreatic cancer. Diabetes was identified as a risk factor for the development of pancreatic cancer, but the mechanism remains unknown. In this project, the objective was to delineate a link between diabetes and pancreatic cancer by examining their shared protein signaling pathways. In a previous study, hyper-activation of AKT1 resulted in a pre-diabetic phenotype and also increased upregulation of downstream phosphorylated mTOR and phosphorylated p70S6 kinase. More recently, mice with mutations that hyper-activated AKT1 and KRAS showed a significantly higher blood glucose level compared to littermate matched wild-type, mutant AKT1, or mutant KRAS mice. Interestingly, mice with a combination of mutations that hyper-activated AKT1 and KRAS also showed faster development of pancreatic cancer compared to these other groups of littermate mice. Toward determining a molecular basis for the crosstalk between AKT1 and KRAS, pancreas and liver tissues were collected from all four groups of mice including wild-type, mutant AKT1, mutant KRAS, and mice with dual AKT1/KRAS hyper-activation. One strategy was to examine expression and/or phosphorylation of downstream protein signaling crosstalk by analysis of p70S6K using Western Blots. Erk 1/2 proteins were also tested as downstream proteins of KRAS to provide a molecular view of the individual and cooperative roles of AKT1 and KRAS in the mouse models. A potential feedback mechanism to affect insulin receptor signaling in the pancreas was examined using enzyme-linked immunosorbent assays (ELISA). A significant decrease in insulin receptor phosphorylation, possibly contributing to insulin resistance, was found when mice had mutant hyper-activated KRAS. Contrary to the original expectations, mice with combined mutations of AKT1 and KRAS may contribute to the accentuated diabetic phenotype by targeting two different points in the AKT and KRAS protein signaling pathways. The information can help understand the relationship between glucose metabolism, diabetes, and pancreatic cancer development. By thoroughly studying the interactions between targets in the AKT1/KRAS signaling pathways, key molecular events that induce metabolic changes and potentially early biomarkers may lead to an improved understanding of risk and/or detection of pancreatic cancer.
323

The Role of Podocalyxin in Breast and Prostate Cancer Aggressiveness

Sizemore, Steven T. 30 September 2008 (has links)
No description available.
324

Effects of Neuronal Nitric Oxide Synthase Signaling on Myocyte Contraction during Beta-Adrenergic Stimulation

Tang, Lifei January 2013 (has links)
No description available.
325

Environmental and gene therapy approaches to improve glycemic control and promote healthy aging

McMurphy, Travis Blaze 19 October 2017 (has links)
No description available.
326

The Involvement of Lyn and the SH2-domain-containing Inositol 5’-Phosphatase 1 (SHIP1) in the Negative Regulation of M-CSF-induced Cellular Signaling Events

Baran, Christopher Phillip 12 May 2003 (has links)
No description available.
327

From celebrex to a novel class of phosphoinositde-dependent kinase-1 (PDK-1) inhibitors for androgen-independent prostate cancer

Zhu, Jiuxiang 02 March 2005 (has links)
No description available.
328

Celecoxib: Its non-cox-2 targets and its anti-cancer effects

Lin, Ho-Pi 24 August 2005 (has links)
No description available.
329

Troglitazone: from an insulin sensitizer to a novel class of anti-cancer agent

Chen, Kuen-Feng 10 October 2005 (has links)
No description available.
330

Keratinocyte growth factor as a survival factor in human breast cancer

Chang, Hsiang-Lin 02 December 2005 (has links)
No description available.

Page generated in 0.0403 seconds